Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation-Reference-Cited by-同舟云学术

Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation

Published:2023-02 Issue:13 Volume:18 Page:e1066-e1076
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Mangner Norman,Brinkert Miriam,Keller Lukas S.,Moriyama Noriaki,Hagemeyer Daniel,Haussig Stephan,Crusius Lisa,Kobza Richard,Abdel-Wahab Mohamed,Laine Mika,Stortecky Stefan,Pilgrim Thomas,Nietlispach Fabian,Ruschitzka Frank,Thiele Holger,Toggweiler Stefan,Linke Axel

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.;Tarantini G;Eur Heart J,2017

2. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

3. Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

4. Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention

5. An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial;EuroIntervention;2023-11

2. Continuation of oral anticoagulation during transcatheter aortic valve implantation: time to change practice?;EuroIntervention;2023-02